Funder
Cancer Society New Zealand
Cancer Research Trust New Zealand
Lottery Health Research
Breast Cancer Foundation New Zealand
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference38 articles.
1. Loganayagam A, Hernandez MA, Corrigan A, Fairbanks L, Lewis C, Harper P, Maisey N, Ross P, Sanderson J, Marinaki A (2013) Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity. Br J Cancer 108(12):2505–2515
2. Peterson D, Boers-Doets C, Bensadoun R, Herrstedt J (2015) Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann Oncol 26(suppl_5):139–v151
3. Kishi P, Price CJ (2018) Life-threatening reaction with topical 5-fluorouracil. Drug Saf Case Rep 5(1):4
4. Peterson D, Bensadoun R-J, Roila F, Group EGW (2011) Management of oral and gastrointestinal mucositis: ESMO clinical practice guidelines. Ann Oncol 22((suppl_6)):vi78–vi84
5. Rosmarin D, Palles C, Church D, Domingo E, Jones A, Johnstone E, Wang H, Love S, Julier P, Scudder C (2014) Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. J Clin Oncol 32(10):1031–1039
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献